Apolipoprotein E DNA Methylation Linked to Cognitive Decline in Postmenopausal Women With Breast Cancer
Molecular Genetics & Genomic Medicine · 2026
DOI: 10.1002/mgg3.70302 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Emily K Mewborn und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Department of Health Promotion and Development, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Apolipoprotein E4, Apolipoproteins E, Breast Neoplasms, Cognitive Dysfunction. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINR NIH HHS, NCI NIH HHS, National Institute of Nursing Research.
Abstract (Originalsprache)
Background
Cognitive decline is common among individuals with breast cancer (BC), and carriage of the apolipoprotein E (APOE) ε4 allele increases risk. APOE DNA methylation (DNAm) may influence cognition through regulation of neuroinflammatory and amyloid‐related pathways. Exercise is a potential factor affecting DNAm and cognition. This study examined associations between APOE DNAm and cognition in postmenopausal women with BC and evaluated moderation by APOE4 carriage status and exercise.
Methods
Data were drawn from a 6‐month randomized trial of moderate‐intensity exercise versus usual care. Cognition was assessed at baseline and 6 months, and change scores were calculated. APOE4 status (carrier, non‐carrier) and baseline DNAm (M‐value) were determined from peripheral blood. Regression models tested cross‐sectional and longitudinal associations, adjusting for age and education. Moderation by APOE4 status and intervention group was also tested.
Results
Among 102 participants, APOE DNAm was consistently suggestively associated with cognition. Higher DNAm at promoter‐region CpGs (cg04406254, cg14123992, cg20051876) was linked to poorer cognition, with direction and magnitude differing by APOE4 status and group. APOE4 carriers with higher DNAm showed better cognitive performance, and exercisers with higher DNAm showed improved outcomes, suggesting exercise may buffer epigenetic effects.
Conclusions
Findings may implicate APOE DNAm as a biomarker of cognition and highlight exercise supporting cognitive health in women with BC, although replication is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing, Department of Health Promotion and Development, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- School of Public Health, Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- AdventHealth Research Institute, Neuroscience Institute, Orlando, Florida, USA.
ORCID-Profile: Emily K Mewborn, Lacey W Heinsberg, Myeong-Ga Cho, Kirk I Erickson, Catherine M Bender
Förderung
- NINR NIH HHS
- NCI NIH HHS
- National Institute of Nursing Research
- National Cancer Institute
Zitieren
APA
Mewborn, E. K., Heinsberg, L. W., Cho, M. G., Erickson, K. I., Bender, C. M., & Conley, Y. P. (2026). Apolipoprotein E DNA Methylation Linked to Cognitive Decline in Postmenopausal Women With Breast Cancer. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70302
Vancouver
Mewborn EK, Heinsberg LW, Cho MG, Erickson KI, Bender CM, Conley YP. Apolipoprotein E DNA Methylation Linked to Cognitive Decline in Postmenopausal Women With Breast Cancer. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70302
BibTeX
@article{Mewborn2026,
author = {Mewborn, Emily K and Heinsberg, Lacey W and Cho, Myeong-Ga and Erickson, Kirk I and Bender, Catherine M and Conley, Yvette P},
title = {Apolipoprotein E DNA Methylation Linked to Cognitive Decline in Postmenopausal Women With Breast Cancer},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
doi = {10.1002/mgg3.70302}
}
EUVIMED